Crinetics Pharmaceuticals
CRNX
CRNX
61 hedge funds and large institutions have $229M invested in Crinetics Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less capital invested
Capital invested by funds: $473M → $229M (-$244M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
61
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.57M | |
| 2 | +$2.18M | |
| 3 | +$2.15M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.99M |
| 5 |
Millennium Management
New York
|
+$829K |
Top Sellers
| 1 | -$84.4M | |
| 2 | -$12.3M | |
| 3 | -$6.55M | |
| 4 |
Goldman Sachs
New York
|
-$1.63M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$1.08M |